Brought to you by 
LipoScience succeeds in its second attempt to go public; nets $48.1mm
04 Feb 2013
Executive Summary
After failing to go public in 2002 and refiling in 2011, LipoScience Inc. (diagnostics for cardiovascular and metabolic conditions) has finally completed its IPO. It sold 5.75mm common shares (including the overallotment) at $9--much lower than the $13-15 price it proposed earlier this month--netting $48.1mm.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- MRI, NMR
-
Diagnostic Imaging Equipment & Supplies
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
LipoScience succeeds in its second attempt to go public; nets $48.1mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice